[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

Viking Therapeutics, Inc (VKTX)

Viking Therapeutics ($VKTX) sees positive sentiment with potential for acquisition and positive trial results. Analysts are bullish on the obesity treatment market and upcoming trial data.

About Viking Therapeutics, Inc

Viking Therapeutics, Inc. (VKTX) is a biopharmaceutical company developing therapies for metabolic and endocrine disorders, particularly obesity.
Viking Therapeutics, Inc uses the ticker $VKTX for trading. Listed in the Stocks and category within the Healthcare sectors.

Price: $XX #

Price 24-Hour Chart Data
The current price dip appears to be related to profit-taking and concerns about potential trial delays, but the overall positive analyst sentiment and the 24-hour change suggest a potential price recovery, supported by the positive sentiment around the initiation of Phase X obesity trials and the potential for an acquisition.

24-Hour	7-Day	30-Day
-XXXX%	XXXX%	XXXXX%

1-Year High: $XX on 2024-10-25
1-Year Low: $XX on 2025-04-08

AltRank: XXX #

AltRank Line Chart
AltRank 24-Hour Chart Data
Viking Therapeutics, Inc (VKTX) is currently AltRank #617 based on combined combined social and market metrics Daily Average: XXX
1 Week: XXX +181
1 Month: XXX -XXX
6 Months: XXX +185
1 Year: XXX +242
1-Year High: XXXXX on 2024-11-24
1-Year Low: X on 2025-02-22

Galaxy Score: XXXXX #

Galaxy Score Line Chart
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -X
1 Month: XX +9
6 Months: XX -X
1 Year: XX +27
1-Year High: XX on 2025-04-29
1-Year Low: X on 2024-11-18

Engagements: XXXXXXX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XXXXXXX
Daily Average: XXXXXXX
1 Week: XXXXXXX -XX%
1 Month: XXXXXXXXX +77%
6 Months: XXXXXXXXXX -XX%
1 Year: XXXXXXXXXX +41%
1-Year High: XXXXXXXXX on 2025-02-04
1-Year Low: XXXXX on 2025-03-30

Social Network	X	YouTube
Engagements	XXXXXXX	XX

Mentions: XXX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Week: XXXXX -XX%
1 Month: XXXXX +85%
6 Months: XXXXXX -XX%
1 Year: XXXXXXX +198%
1-Year High: XXXXX on 2024-12-20
1-Year Low: XXX on 2024-10-06

Social Network	X	YouTube
Mentions	XXXXX	X

Creators: XXX #

Creators Line Chart
Creators 24-Hour Chart Data
XXX unique social accounts have posts mentioning Viking Therapeutics, Inc (VKTX) in the last XX hours which is down XXXX% from XXX in the previous XX hours Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX +293%
6 Months: XXXXX -XX%
1 Year: XXXXX +154%
1-Year High: XXXXX on 2024-11-05
1-Year Low: XX on 2025-03-30

The most influential creators that mention Viking Therapeutics, Inc in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@kiantrades	X	XXXXXX	X	XXXXXX
@AponiaAnalytics	X	XXXXX	XX	XXXXX
@bioinvestor24	X	XXXXX	X	XXXXX
@OMillionaires	X	XXXXXXX	X	XXXXX
@Pharmdca	X	XXXXXXX	X	XXXXX
@Trader83117	X	XX	X	XXXXX
@SeanValenc89161	X	XX	X	XXXXX
@StockSqueezeSpy	X	XXXXX	X	XXXXX
@john10767_john	X	XX	X	XXXXX
@Mufaso7	XX	XXXXX	X	XXXXX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +7%
1 Month: XX% -X%
6 Months: XX% +26%
1 Year: XX% +45%
1-Year High: XXX% on 2024-11-12
1-Year Low: XX% on 2024-07-24

Most Supportive Themes

Positive Data Expectations and Takeover Speculation: (55%) Positive expectations for Phase X data and the potential for a takeover or partnership are driving bullish sentiment.
Bullish Analyst Sentiment: (25%) The obesity treatment market position, positive analyst sentiment, and upcoming trial data are contributing to an optimistic view.

Most Critical Themes

Concerns About Trial Delays and Dilution: (6%) Some investors voice concerns about potential trial delays and stock dilution.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXXXXX	XX%	XXXXXX	XX%	XXXXX	X%
YouTube	X	X%	XX	X%	X	X%

Total	XXXXXX	XX%	XXXXXX	XX%	XXXXX	X%

Social Dominance: XXXXX% #

Social Dominance Line Chart
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% -XXXXX%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXX% on 2024-11-05
1-Year Low: XXXXX% on 2025-07-14

Market Dominance: XXXXXXX% #

Market Dominance Line Chart
Market Dominance 24-Hour Chart Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2024-09-12
1-Year Low: XXXXXXX% on 2025-06-23

Market Cap: $XXXXXXXXXXXXX #

Market Cap Line Chart
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXX +$2.50%
1 Month: $XXXXXXXXXXXXX +$22%
6 Months: $XXXXXXXXXXXXX -$1.20%
1 Year: $XXXXXXXXXXXXX -$35%
1-Year High: $XXXXXXXXXXXXX on 2024-10-25
1-Year Low: $XXXXXXXXXXXXX on 2025-04-08

Top assets mentioned In the posts about Viking Therapeutics, Inc in the last XX hours

Hims & Hers Health, Inc. (HIMS) Eli Lilly and Company (LLY) Eli Lilly and Company (LLY) Bitcoin Incognito (XBI) MEI Pharma, Inc. (MEIP) Viking Holdings Ltd (VIK) Pfizer, Inc. (PFE) Novo-Nordisk (NVO) MicroCloud Hologram Inc. (HOLO)

Top topics mentioned In the posts about Viking Therapeutics, Inc in the last XX hours

hims, $hims, manat, $vani, spy, pfe, nvda, gns, $lly, $gwav, $zldpf, stocks healthcare, gme, qqq, $xtia, wmt, $ipw, meta, eli lilly, dawn, $bsfc, $ctnt, celz, $xbi, $cyn, $achl, $bntc, $crkn, amzn, $meip, stocks, weight loss, acquisition, $vik, pltr, $pfe, $ffie, alt, $nvo, googl, $gpcr, investment, mauritian rupee, jpm, msft, oscr, bmnr, ndra, drugs, asts, hood, gibraltar pound, pam, $holo, $tsla, $vrna, money, $wksp, abbv, $sofi, $etsy, nio, china, $mdgl, jnj, $mrk, $meta, $alt, $tlry, stockmarket, $muln, le, baba, $jdzg, $inbx, $gsk, crcl, $rblx, vale, smci, sqns, nke, qbts, $mtsr, $mngl, rklb, $pipr, trader, goog, $regn, wegovy, bron, $tern, $alny, spx, $btc, elf, $deck, mstr, novo